AT
TMO icon

American Trust’s Thermo Fisher Scientific TMO Stock Holding History

American Trust’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.06M Sell
4,117
-515
-11% -$247K 0.16% 73
2026
Q1 		$2.28M Sell
4,632
-865
-16% -$469K 0.2% 66
2025
Q4 		$3.19M Sell
5,497
-36
-0.7% -$20.4K 0.27% 58
2025
Q3 		$2.68M Sell
5,533
-130
-2% -$60.5K 0.23% 71
2025
Q2 		$2.3M Buy
5,663
+93
+2% +$38.9K 0.22% 75
2025
Q1 		$2.77M Buy
5,570
+1,718
+45% +$930K 0.68% 44
2024
Q4 		$2M Sell
3,852
-1,564
-29% -$860K 0.15% 88
2024
Q3 		$3.35M Sell
5,416
-878
-14% -$520K 0.28% 58
2024
Q2 		$3.48M Sell
6,294
-301
-5% -$172K 0.29% 59
2024
Q1 		$3.83M Sell
6,595
-46
-0.7% -$25.8K 0.32% 62
2023
Q4 		$3.52M Sell
6,641
-231
-3% -$112K 0.26% 67
2023
Q3 		$3.48M Buy
6,872
+168
+3% +$89.5K 0.27% 61
2023
Q2 		$3.5M Sell
6,704
-39
-0.6% -$21K 0.24% 78
2023
Q1 		$3.89M Buy
6,743
+784
+13% +$442K 0.27% 71
2022
Q4 		$3.28M Sell
5,959
-745
-11% -$395K 0.3% 85
2022
Q3 		$3.4M Buy
6,704
+531
+9% +$297K 0.29% 67
2022
Q2 		$3.35M Sell
6,173
-516
-8% -$284K 0.27% 76
2022
Q1 		$3.95M Buy
6,689
+102
+2% +$58.6K 0.27% 74
2021
Q4 		$4.39M Buy
+6,587
New +$4.11M 0.34% 58

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

American Trust's TMO Position: Q2 2026 in Review

American Trust reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, selling an estimated $247K and leaving 4,117 shares worth $2.06M. The position accounts for 0.16% of the portfolio, ranked #73.

American Trust first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.39M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • American Trust held 4,117 shares of Thermo Fisher Scientific worth $2.06M as of Q2 2026.
  • American Trust sold 515 Thermo Fisher Scientific shares in Q2 2026, an estimated $247K.
  • Thermo Fisher Scientific made up 0.16% of American Trust's portfolio in Q2 2026, its #73 holding.
  • American Trust first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • American Trust's Thermo Fisher Scientific position peaked at $4.39M in Q4 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on American Trust's 13F filing for Q2 2026, filed 14 Aug 2026.